| |
| |
|
| Insider
Information: |
Morris Richard Steven |
| Relationship: |
Chief Financial Officer |
| City: |
Exton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
6,698 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,036 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,698 |
|
|
| Total
Value |
$7,036 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -40.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viropharma Inc |
VPHM |
Chief Accounting Officer |
2012-03-05 |
1,244 |
|
0 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
Chief Financial Officer |
2016-10-25 |
0 |
2016-04-29 |
0 |
Premium* |
|
|
Passage Bio, Inc. |
PASG |
Chief Financial Officer |
2021-05-21 |
5,454 |
2020-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PASG |
Passage Bio, Inc. |
Chief Financial Officer |
• – – |
2021-05-21 |
4 |
B |
$13.82 |
$30,000 |
D/D |
2,171 |
5,454 |
2.74 |
% |
|
| PASG |
Passage Bio, Inc. |
Chief Financial Officer |
• – – |
2020-03-03 |
4 |
B |
$18.00 |
$7,200 |
D/D |
400 |
400 |
2.74 |
% |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2016-10-25 |
4 |
D |
$21.00 |
$17,388 |
D/D |
(828) |
0 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2016-04-29 |
4 |
A |
$6.11 |
$5,059 |
D/D |
828 |
828 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Chief Accounting Officer |
• – – |
2012-03-05 |
4 |
S |
$33.01 |
$174,953 |
D/D |
(5,300) |
1,244 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Chief Accounting Officer |
• – – |
2012-03-05 |
4 |
OE |
$5.91 |
$35,085 |
D/D |
5,300 |
6,544 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Chief Accounting Officer |
• – – |
2011-11-16 |
4 |
OE |
$20.28 |
$40,560 |
D/D |
2,000 |
3,165 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Chief Accounting Officer |
• – – |
2011-11-16 |
4 |
S |
$22.59 |
$45,181 |
D/D |
(2,000) |
1,165 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Chief Accounting Officer |
• – – |
2010-12-09 |
4 |
OE |
$3.14 |
$43,115 |
D/D |
13,300 |
13,869 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Chief Accounting Officer |
• – – |
2010-12-09 |
4 |
S |
$16.56 |
$220,248 |
D/D |
(13,300) |
569 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Chief Accounting Officer |
• – – |
2010-12-08 |
4 |
S |
$16.55 |
$19,860 |
D/D |
(1,200) |
569 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Chief Accounting Officer |
• – – |
2010-12-08 |
4 |
OE |
$3.55 |
$4,260 |
D/D |
1,200 |
1,769 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Chief Accounting Officer |
• – – |
2008-09-11 |
4 |
S |
$14.29 |
$31,454 |
D/D |
(2,200) |
392 |
0 |
- |
|
| VPHM |
Viropharma Inc |
Chief Accounting OfficerOffice |
• – – |
2008-04-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,592 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
